mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.06 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
0.06 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.06 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.06 |
mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.06 |
mRNA |
StemRegenin 1 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.06 |
mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.07 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.07 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.094 |
0.07 |
mRNA |
ML258 |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.07 |